PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: marketing

Biologics for Psoriasis and Psoriatic ... - Veterans Affairs

Review of Biologic Agents for Psoriasis and Psoriatic Arthritis Updated versions may be found at or 1 Biologics for Psoriasis and Psoriatic Arthritis (Adalimumab, Etanercept, Golimumab, Infliximab, Ustekinumab) National PBM Criteria for Use Monograph with Literature Review June 2013 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives The purpose of VA PBM Services drug monographs is to provide a comprehensive drug review for making formulary decisions. These documents will be updated when new clinical data warrant additional formulary discussion. Documents will be placed in the Archive section when the information is deemed to be no longer current. EXECUTIVE SUMMARY The purposes of this updated review of antipsoriatic biologic agents are to compare their pharmacologic properties and evaluate studies that address certain key clinical questions that are pertinent to the development of criteria for use of biologic agents for chronic plaque Psoriasis (CPP) and Psoriatic arthritis (PsA) in the Veterans Health Administration.

progression of joint erosion. PsA Q3. In patients with psoriatic arthritis, is there a difference among antipsoriatic biologic agents in terms of efficacy, effectiveness, safety, or tolerability when used in nonbiologic systemic treatment ... world practice, the incremental gain in effectiveness of biologic agents over methotrexate is small and ...

Tags:

  Progression, Incremental

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Biologics for Psoriasis and Psoriatic ... - Veterans Affairs

Related search queries